| Financial Year |
March 31 2023 |
| Monetary Funds |
14,643,231.59 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
3,629,725.08 |
| Accounts Receivable |
156,162,166.99 |
| Advances to Suppliers |
13,513,542.26 |
| Other Receivables |
45,630,991.49 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
129,249,925.67 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,251,381.56 |
| Total Current Assets |
369,080,964.64 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
5,333,093.11 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
130,275,533.05 |
| Under-construction Projects |
275,229.36 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
16,560,498.78 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
529,260.03 |
| Deferred Income Tax Assets |
33,031,018.76 |
| Other Non-Current Assets |
2,026,136.60 |
| Sub-Total of Non-Current Assets |
195,144,342.38 |
| Total Assets |
564,225,307.02 |
| Short-Term Loans |
5,085,798.78 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
107,508,065.10 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
23,251,168.11 |
| Taxes Payable |
606,465.91 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
130,287,788.04 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,215,485.39 |
| Other Current Liabilities |
7,714,208.78 |
| Sub-Total of Current Liabilities |
350,375,298.66 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
258,165.75 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
11,663,262.86 |
| Total Liabilities |
362,038,561.52 |
| Paid-In Capital(Or Share Stock) |
167,150,000.00 |
| Capital Surplus |
241,704,852.52 |
| Surplus Reserve |
31,300,427.78 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-238,223,131.83 |
| Minority Stockholder's Interest |
1,081,054.77 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
201,105,690.73 |
| Owner's Equity（Stockholder's Equity） |
202,186,745.50 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
564,225,307.02 |
